PSMA Expression in Solid Tumors beyond the Prostate Gland: Ready for Theranostic Applications?

PET/CT PSMA cancer radioligand therapy theranostics

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
07 Nov 2022
Historique:
received: 19 09 2022
revised: 02 11 2022
accepted: 04 11 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

In the past decades, the expanding use of prostate-specific membrane antigen (PSMA) imaging for prostate cancer has led to the incidental detection of a lot of extra-prostatic malignancies showing an increased uptake of PSMA. Due to these incidental findings, the increasing amount of immunohistochemistry studies and the deeper knowledge of the mechanisms of expression of this antigen, it is now clear that "PSMA" is a misnomer, since it is not specific to the prostate gland. Nevertheless, this lack of specificity could represent an interesting opportunity to bring new insights on the biology of PSMA and its sites of expression to image and treat new conditions, particularly several cancers. In this review, we will describe the main extra-prostatic cancers that exhibit PSMA expression and that can be studied with PSMA-based positron emission tomography-computed tomography (PET/CT) as an additional or alternative tool to conventional imaging. In particular, we will focus on cancers in which a radioligand therapy with

Identifiants

pubmed: 36362824
pii: jcm11216590
doi: 10.3390/jcm11216590
pmc: PMC9657217
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Clin Nucl Med. 2022 May 1;47(5):e423-e424
pubmed: 35234196
Clin Nucl Med. 2016 May;41(5):e263-5
pubmed: 26914556
Clin Nucl Med. 2020 Dec;45(12):e512-e513
pubmed: 32558721
Surg Oncol Clin N Am. 2016 Jul;25(3):447-68
pubmed: 27261908
Bull Exp Biol Med. 2021 Aug;171(4):468-471
pubmed: 34542759
EJNMMI Res. 2020 Oct 22;10(1):128
pubmed: 33090273
Clin Nucl Med. 2022 Oct 1;47(10):892-894
pubmed: 35439183
World J Nucl Med. 2019 Dec 18;18(4):406-408
pubmed: 31933557
Cancers (Basel). 2019 Sep 17;11(9):
pubmed: 31533238
Med Oncol. 2020 Oct 9;37(11):98
pubmed: 33034761
Cancers (Basel). 2021 Nov 14;13(22):
pubmed: 34830843
Ann Nucl Med. 2015 Dec;29(10):877-82
pubmed: 26286635
Curr Opin Endocrinol Diabetes Obes. 2017 Oct;24(5):332-336
pubmed: 28692457
Clin Nucl Med. 2017 Jan;42(1):56-57
pubmed: 27764044
Appl Immunohistochem Mol Morphol. 2017 Apr;25(4):271-276
pubmed: 26862945
Hormones (Athens). 2019 Jun;18(2):145-149
pubmed: 30989578
Nucl Med Mol Imaging. 2019 Dec;53(6):442-445
pubmed: 31867081
J Nucl Med Technol. 2009 Sep;37(3):164-9
pubmed: 19692456
Med Oncol. 2012 Sep;29(3):2234-9
pubmed: 22009216
Molecules. 2014 Dec 08;19(12):20536-20556
pubmed: 25493636
Clin Nucl Med. 2018 Feb;43(2):117-119
pubmed: 29261620
Cancer Imaging. 2020 Mar 14;20(1):23
pubmed: 32169115
J Cutan Pathol. 2020 Dec;47(12):1115-1122
pubmed: 32529651
Theranostics. 2020 Jan 12;10(5):2273-2283
pubmed: 32089741
Eur Radiol. 2021 Apr;31(4):2199-2208
pubmed: 33001304
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4350-4368
pubmed: 34120192
J Nucl Med. 2017 Dec;58(12):1938-1942
pubmed: 28572488
Arch Pathol Lab Med. 2011 Nov;135(11):1486-9
pubmed: 22032578
EJNMMI Res. 2020 Mar 6;10(1):18
pubmed: 32144510
Breast Cancer Res Treat. 2018 Jun;169(3):447-455
pubmed: 29455299
Clin Nucl Med. 2020 Jul;45(7):e309-e310
pubmed: 32404709
J Nucl Med. 2016 Mar;57(3):367-71
pubmed: 26585062
PLoS One. 2017 Oct 27;12(10):e0186280
pubmed: 29077706
EJNMMI Res. 2016 Dec;6(1):76
pubmed: 27771904
J Urol. 2018 Feb;199(2):370-377
pubmed: 28827104
Clin Genitourin Cancer. 2018 Jun;16(3):e525-e527
pubmed: 29716834
Clin Nucl Med. 2018 Aug;43(8):e265-e268
pubmed: 29894335
Clin Nucl Med. 2017 Jun;42(6):446-447
pubmed: 28346248
Biomed Res Int. 2017;2017:2847303
pubmed: 29209626
J Nucl Med. 2018 Jun;59(6):871-877
pubmed: 29545375
Clin Nucl Med. 2016 Dec;41(12):e517-e519
pubmed: 27749421
Curr Radiopharm. 2020;13(2):94-98
pubmed: 31625482
Sci Rep. 2017 Jul 12;7(1):5202
pubmed: 28701709
Ann Nucl Med. 2018 Jan;32(1):69-74
pubmed: 29067547
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1605-1606
pubmed: 32040612
Mol Imaging Radionucl Ther. 2021 Jun 3;30(2):79-85
pubmed: 34082503
Iran J Pathol. 2018 Winter;13(1):45-53
pubmed: 29731795
Contemp Oncol (Pozn). 2021;25(1):45-52
pubmed: 33911981
BJU Int. 2019 Nov;124 Suppl 1:5-13
pubmed: 31638341
PLoS One. 2015 May 15;10(5):e0125924
pubmed: 25978404
Clin Nucl Med. 2018 Apr;43(4):282-283
pubmed: 29432341
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59
pubmed: 18670773
Breast Cancer Res. 2019 Oct 22;21(1):116
pubmed: 31640747
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):689-694
pubmed: 27822700
Mol Imaging Biol. 2019 Jun;21(3):567-573
pubmed: 30218388
Clin Nucl Med. 2017 Jan;42(1):20-25
pubmed: 27846003
Clin Exp Metastasis. 2017 Dec;34(8):479-490
pubmed: 29426963
Cancer Res. 1999 Jul 1;59(13):3192-8
pubmed: 10397265
Nat Rev Urol. 2020 Feb;17(2):107-118
pubmed: 31937920
Clin Nucl Med. 2018 Jan;43(1):60-61
pubmed: 29166327
Eur Urol. 2017 Jan;71(1):145-146
pubmed: 27363386
Clin Nucl Med. 2017 Mar;42(3):225-226
pubmed: 27997423
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
AJR Am J Roentgenol. 2011 Aug;197(2):W260-5
pubmed: 21785051
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1276-1277
pubmed: 29572728
Clin Nucl Med. 2020 Jan;45(1):11-18
pubmed: 31663868
Clin Transl Radiat Oncol. 2017 Nov 14;7:79-82
pubmed: 29594233
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):102-107
pubmed: 26996777
J Nucl Med. 2017 Sep;58(Suppl 2):67S-76S
pubmed: 28864615
Eur Urol. 2019 Jan;75(1):74-84
pubmed: 30243799
J Pers Med. 2022 Mar 31;12(4):
pubmed: 35455669
Clin Nucl Med. 2016 Mar;41(3):e167-8
pubmed: 26571447
Clin Cancer Res. 2000 Oct;6(10):4049-54
pubmed: 11051255
Clin Genitourin Cancer. 2017 Aug 23;:
pubmed: 28890070
APMIS. 2014 Jun;122(6):482-9
pubmed: 24304465
Clin Nucl Med. 2019 Sep;44(9):702-706
pubmed: 31348076
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544
pubmed: 31440799
J Nucl Med. 2018 Jul 12;60(2):185-191
pubmed: 30002112
Clin Nucl Med. 2018 Dec;43(12):e488-e491
pubmed: 30358621
EJNMMI Res. 2021 Dec 14;11(1):126
pubmed: 34905121
Histopathology. 2007 Mar;50(4):472-83
pubmed: 17448023
Head Neck Pathol. 2022 May 11;:
pubmed: 35546652
Clin Nucl Med. 2021 May 1;46(5):415-418
pubmed: 33630811
Theranostics. 2015 Oct 18;5(12):1388-401
pubmed: 26681984
Clin Nucl Med. 2020 Dec;45(12):1016-1017
pubmed: 32956110
Clin Nucl Med. 2021 Apr 1;46(4):e233-e235
pubmed: 33031232
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1461-2
pubmed: 24756358
J Nucl Med. 2020 Nov;61(11):1576-1579
pubmed: 32358088
J Clin Oncol. 2007 Feb 10;25(5):540-7
pubmed: 17290063
Oncol Rep. 2014 Feb;31(2):701-6
pubmed: 24297035
Lancet. 2017 Jan 21;389(10066):299-311
pubmed: 27574741
J Nucl Med. 2019 Sep;60(9):1270-1276
pubmed: 30737300
J Nucl Med. 2021 Sep 1;62(9):1235-1241
pubmed: 33509970
EJNMMI Res. 2021 Feb 9;11(1):11
pubmed: 33559764
Am J Nucl Med Mol Imaging. 2020 Jun 15;10(3):135-142
pubmed: 32704404
Oncotarget. 2017 Jan 17;8(3):4268-4276
pubmed: 28002805
Hum Pathol. 2009 Dec;40(12):1754-61
pubmed: 19716160
Front Endocrinol (Lausanne). 2021 Dec 22;12:794759
pubmed: 35002972
J Med Imaging Radiat Oncol. 2017 Jun;61(3):372-378
pubmed: 28116853
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Urol Case Rep. 2017 Oct 05;16:4-5
pubmed: 29034176
Head Neck Pathol. 2022 Jun;16(2):427-433
pubmed: 34420181
Mod Pathol. 2012 Aug;25(8):1079-85
pubmed: 22460809
Pathol Res Pract. 2014 Nov;210(11):759-63
pubmed: 24951241
Mod Pathol. 2011 Nov;24(11):1521-9
pubmed: 21725290
Semin Nucl Med. 2019 Jul;49(4):255-270
pubmed: 31227049
J Nucl Med. 2018 Jul;59(7):1007-1013
pubmed: 29674422
Clin Nucl Med. 2016 Jan;41(1):83-5
pubmed: 26402128
Clin Nucl Med. 2021 Apr 1;46(4):e212-e213
pubmed: 33156050
Clin Nucl Med. 2022 Dec 1;47(12):1103-1104
pubmed: 35835124
Eur Urol Focus. 2020 Jan 15;6(1):146-150
pubmed: 30120074
Indian J Nucl Med. 2016 Jul-Sep;31(3):222-4
pubmed: 27385897
Clin Nucl Med. 2020 Jan;45(1):e57-e58
pubmed: 31524682
Clin Nucl Med. 2017 Jul;42(7):532-533
pubmed: 28525451
Clin Nucl Med. 2017 Oct;42(10):e447-e448
pubmed: 28759526
Diagnostics (Basel). 2021 Jan 15;11(1):
pubmed: 33467540
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1614-1621
pubmed: 28593386
Med Oncol. 2014 Mar;31(3):857
pubmed: 24477651

Auteurs

Chiara Lauri (C)

Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, "Sapienza" University, 00161 Rome, Italy.

Lorenzo Chiurchioni (L)

Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, "Sapienza" University, 00161 Rome, Italy.

Vincenzo Marcello Russo (VM)

Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, "Sapienza" University, 00161 Rome, Italy.

Luca Zannini (L)

Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, "Sapienza" University, 00161 Rome, Italy.

Alberto Signore (A)

Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, "Sapienza" University, 00161 Rome, Italy.

Classifications MeSH